Anika Therapeutics | ANIK - Zobowiązania





Zobowiązania Zmiana Data
Abbott USD 16.15B 1.66B 2026-09
Agenus USD 231.82M 17.42M 2026-06
Agios Pharmaceuticals USD 77.59M 7.37M 2026-09
Anika Therapeutics USD 22.15M 1.18M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Halozyme Therapeutics USD 476.09M 131.65M 2026-09
Heron Therapeutics USD 92.14M 1.63M 2026-06
Insmed USD 596.57M 157.83M 2026-09
Integra LifeSciences USD 329M 1.88M 2026-09
Intrexon USD 23.02M 38K 2024-06
J&J USD 55.46B 562M 2026-09
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Ligand Pharmaceuticals USD 500.57M 453.83M 2026-09
MacroGenics USD 108.82M 12.88M 2026-06
Merit Medical Systems USD 265.08M 150K 2026-09
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 29.77B 2.16B 2026-09
Smith & Nephew USD 2.05B 510M 2026-06
Stryker USD 6.5B 184M 2026-09
Veracyte USD 84.21M 21.47M 2026-09
Xencor USD 76.27M 5.6M 2026-09
Zimmer Biomet Holdings USD 3.5B 488.9M 2026-09